Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 29, 2023
Abstract
The
full
text
of
this
preprint
has
been
withdrawn
by
the
authors
due
to
author
disagreement
with
posting
preprint.
Therefore,
do
not
wish
work
be
cited
as
a
reference.
Questions
should
directed
corresponding
author.
Stem Cell Reviews and Reports,
Journal Year:
2023,
Volume and Issue:
19(5), P. 1214 - 1231
Published: April 14, 2023
Abstract
Mesenchymal
stem
cells
(MSCs)
are
regarded
as
highly
promising
for
allogeneic
cell
therapy,
owing
to
their
multipotent
nature
and
ability
display
potent
varied
functions
in
different
diseases.
The
of
MSCs,
including
native
immunomodulation,
high
self-renewal
characteristic,
secretory
trophic
properties,
can
be
employed
improve
the
immune-modulatory
MSCs
impact
most
immune
by
directly
contacting
and/or
secreting
positive
microenvironmental
factors
influence
them.
Previous
studies
have
reported
that
immunomodulatory
role
is
basically
dependent
on
secretion
from
MSCs.
This
review
discusses
capabilities
strategies
successfully
potential
utilization
clinical
research.
Graphical
Frontiers in Neurology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 5, 2025
Traumatic
brain
injury
(TBI)
is
a
complex
condition
involving
mechanisms
that
lead
to
dysfunction
and
nerve
damage,
resulting
in
significant
morbidity
mortality
globally.
Affecting
~50
million
people
annually,
TBI's
impact
includes
high
death
rate,
exceeding
of
heart
disease
cancer.
Complications
arising
from
TBI
encompass
concussion,
cerebral
hemorrhage,
tumors,
encephalitis,
delayed
apoptosis,
necrosis.
Current
treatment
methods,
such
as
pharmacotherapy
with
dihydropyridines,
high-pressure
oxygen
therapy,
behavioral
non-invasive
stimulation,
have
shown
limited
efficacy.
A
comprehensive
understanding
vascular
components
essential
for
developing
new
treatments
improve
blood
vessel-related
damage.
Recently,
mesenchymal
stem
cells
(MSCs)
promising
results
repairing
mitigating
Studies
indicate
MSCs
can
promote
neurogenesis
angiogenesis
through
various
mechanisms,
including
releasing
bioactive
molecules
extracellular
vesicles
(EVs),
which
help
reduce
neuroinflammation.
In
research,
the
distinctive
characteristics
positioned
them
highly
desirable
cell
sources.
Extensive
investigations
been
conducted
on
regulatory
properties
their
manipulation,
tagging,
transportation
techniques
brain-related
applications.
This
review
explores
progress
prospects
MSC
therapy
TBI,
focusing
action,
therapeutic
benefits,
challenges
potential
limitations
using
treating
neurological
disorders.
Journal of Inflammation Research,
Journal Year:
2024,
Volume and Issue:
Volume 17, P. 1643 - 1658
Published: March 1, 2024
Background:
Intracerebral
hemorrhage
(ICH),
a
devastating
form
of
stroke,
is
characterized
by
elevated
morbidity
and
mortality
rates.
Neuroinflammation
common
occurrence
following
ICH.
Mesenchymal
stem
cells
(MSCs)
have
exhibited
potential
in
treating
brain
diseases
due
to
their
anti-inflammatory
properties.
However,
the
therapeutic
efficacy
MSCs
limited
intense
inflammatory
response
at
transplantation
site
Hence,
enhancing
function
transplanted
holds
considerable
promise
as
strategy
for
Notably,
iron-quercetin
complex
(IronQ),
metal-quercetin
synthesized
through
coordination
chemistry,
has
garnered
significant
attention
its
biomedical
applications.
In
our
previous
studies,
we
observed
that
IronQ
exerts
stimulatory
effects
on
cell
growth,
notably
survival
viability
peripheral
blood
mononuclear
(PBMCs)
MSCs.
This
study
aimed
evaluate
pretreated
with
neuroinflammation
elucidate
underlying
mechanisms.
Methods:
The
ICH
mice
were
induced
injecting
collagenase
I
solution
into
right
caudate
nucleus.
After
24
hours,
randomly
divided
four
subgroups,
model
group
(Model),
quercetin
(Quercetin),
(MSCs),
(MSCs+IronQ).
Neurological
deficits
re-evaluated
day
3,
samples
collected
further
analysis.
TUNEL
staining
was
performed
assess
DNA
damage,
protein
expression
levels
factors
cGAS-STING
signaling
pathway
investigated
analyzed.
Results:
Pretreated
effectively
mitigate
neurological
reduce
neuronal
inflammation
modulating
microglial
polarization.
Moreover,
suppress
pathway.
Conclusion:
These
findings
suggest
demonstrate
synergistic
effect
alleviating
neuroinflammation,
thereby
improving
function,
which
achieved
inhibition
Keywords:
mesenchymal
cells,
IronQ,
intracerebral
hemorrhage,
cGAS/STING/NFκB,
Journal of Xenobiotics,
Journal Year:
2024,
Volume and Issue:
14(3), P. 827 - 872
Published: June 24, 2024
In
the
recent
past,
formulation
and
development
of
nanocarriers
has
been
elaborated
into
broader
fields
opened
various
avenues
in
their
preclinical
clinical
applications.
particular,
cellular
membrane-based
nanoformulations
have
formulated
to
surpass
surmount
limitations
restrictions
associated
with
naïve
or
free
forms
therapeutic
compounds
circumvent
physicochemical
immunological
barriers
including
but
not
limited
systemic
barriers,
microenvironmental
roadblocks,
other
subcellular
hinderances-which
are
quite
heterogeneous
throughout
diseases
patient
cohorts.
These
drug
delivery
overcome
through
mesenchymal
cells
precision
therapeutics,
where
these
interventions
led
significant
enhancements
efficacies.
However,
still
focuses
on
optimization
paradigms
a
one-size-fits-all
resolutions.
As
stem
cell
engineered
highly
diversified
fashions,
being
optimized
for
delivering
payloads
more
better
personalized
modes,
entering
arena
as
well
nanomedicine.
this
Review,
we
included
some
advanced
which
designed
utilized
both
non-personalized
applicability
can
be
employed
improvements
nanotherapeutics.
present
report,
authors
focused
aspects
advancements
nanoparticle
conceptions
several
roadblocks
It
suggested
that
well-informed
designing
will
lead
appreciable
efficacy
payload
approaches
also
enable
tailored
customized
designs
MSC-based
applications,
finally
amending
outcomes.
Frontiers in Molecular Neuroscience,
Journal Year:
2022,
Volume and Issue:
15
Published: Oct. 11, 2022
Microglia
are
the
resident
immune
cells
of
central
nervous
system
(CNS)
and
play
a
key
role
in
neurological
diseases,
including
intracerebral
hemorrhage
(ICH).
activated
to
acquire
either
pro-inflammatory
or
anti-inflammatory
phenotypes.
After
onset
ICH,
mediators
produced
by
microglia
at
early
stages
serve
as
crucial
character
neuroinflammation.
Conversely,
switching
microglial
shift
an
phenotype
could
alleviate
inflammatory
response
incite
recovery.
This
review
will
elucidate
dynamic
profiles
phenotypes
their
available
following
ICH.
study
can
facilitate
understanding
self-regulatory
functions
involving
Moreover,
suggestions
for
future
preclinical
clinical
research
potential
intervention
strategies
discussed.
Stem Cell Research & Therapy,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Aug. 13, 2024
Hemorrhagic
stroke
is
a
devastating
cerebrovascular
event
with
high
rate
of
early
mortality
and
long-term
disability.
The
therapeutic
potential
mesenchymal
stem
cell-derived
extracellular
vesicles
(MSC-EVs)
for
neurological
conditions,
such
as
intracerebral
hemorrhage
(ICH),
has
garnered
considerable
interest,
though
their
mechanisms
action
remain
poorly
understood.
Frontiers in Cell and Developmental Biology,
Journal Year:
2024,
Volume and Issue:
12
Published: Feb. 6, 2024
The
vasculature
system
is
composed
of
a
multiplicity
juxtaposed
cells
to
generate
functional
biological
barrier
between
the
blood
and
tissues.
On
luminal
surface
vessels,
endothelial
(ECs)
are
in
close
contact
with
circulating
while
supporting
basal
lamina
pericytes
wrap
abluminal
surface.
Thus,
reciprocal
interaction
ECs
vital
element
physiological
activity
vascular
system.
Several
reports
have
indicated
that
occurrence
pericyte
dysfunction
under
ischemic
degenerative
conditions
results
varied
micro
macro-vascular
complications.
Emerging
evidence
points
fact
autophagy,
conserved
self-digestive
cell
machinery,
can
regulate
several
like
response
various
stresses
pathological
conditions.
Here,
we
aim
highlight
role
autophagic
angiogenesis
potential
following
different
Translational Stroke Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 1, 2024
Abstract
Intracerebral
hemorrhage
(ICH)
is
the
most
serious
form
of
stroke
and
has
limited
available
therapeutic
options.
As
knowledge
on
ICH
rapidly
develops,
cutting-edge
techniques
in
fields
surgical
robots,
regenerative
medicine,
neurorehabilitation
may
revolutionize
treatment.
However,
these
new
advances
still
must
be
translated
into
clinical
practice.
In
this
review,
we
examined
several
emerging
strategies
their
major
challenges
managing
ICH,
with
a
particular
focus
innovative
therapies
involving
robot-assisted
minimally
invasive
surgery,
stem
cell
transplantation,
situ
neuronal
reprogramming,
brain-computer
interfaces.
Despite
expansion
drug
armamentarium
for
over
past
few
decades,
judicious
selection
more
efficacious
modalities
exploration
multimodal
combination
represent
opportunities
to
improve
patient
prognoses
after
ICH.